Two peptides derivate from Acinetobacter baumannii outer membrane protein K as vaccine candidates: A comprehensive in silico study
Research Square
2023
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
Background The lack of appropriate vaccines is an obstacle to the effective management of A. baumannii infections. Peptide vaccines can provide attractive and promising preventive strategies against A. baumannii. Objective Here, specific T cell epitopes of A. baumannii outer membrane protein K (OMPK) were found using comprehensive bioinformatics and detailed molecular docking analysis. Methods Both class-I and class-II T cell epitopes of A. baumannii OMPK were predicted by three tools namely IEDB, SYFPEITHI, and ProPred. The predicted epitopes were shortlisted via several analyses such as prediction scoring, clustering, human similarity exclusion, considering immunogenicity and cytokine production, and removing toxic and/or allergen epitopes. The epitopic peptides with high prediction scores and appropriate properties that contained both class-I and class-II T cell epitopes were selected. Two of these class I/II epitopic peptides were chosen for molecular docking studies and assessing their physicochemical properties as vaccine candidates. Results The results showed many T-cell epitopes of OMPK that could be evaluated for possible immunogenicity. Two of these epitopes (containing both class-I and II epitopes) had high prediction scores, predicted by several tools, attached to several HLAs, and had the best docking score (bind efficiently to their specific HLAs). They had different physicochemical properties and were conserved among Acinetobacter species. Discussion We identified the A. baumannii OMPK high immunogenic class-I and class-II T cell epitopes and introduced two promising high immunogenic peptides as vaccine candidates. It is recommended to do an in vitro/in vivo investigation of these peptides to determine their true efficacy and efficiency.
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know